Stevanato Group S.p.A (STVN) Current Deferred Revenue (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Current Deferred Revenue came in at $13.6 million in Q1 2026, up 12.93% year-on-year from $12.0 million in Q1 2025, and up 12.02% on a QoQ basis from $12.1 million in Q4 2025.
Stevanato Group S.p.A (STVN) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Current Deferred Revenue data on file, last reported at $13.6 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue rose 12.93% year-over-year to $13.6 million in Q1 2026; TTM through Mar 2026 was $13.6 million, a 12.93% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 168.75% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $13.6 million, up from $12.1 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for STVN reached as high as $28.0 million in Q1 2024 and fell as low as -$24.0 million in Q4 2023.
- Historically, Current Deferred Revenue has averaged $10.6 million across 5 years, with a median of $12.1 million in 2025.
- Across the five-year window, Current Deferred Revenue soared 242.16% in 2022 and slumped 63.44% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at -$15.1 million in 2022, then plunged by 58.9% to -$24.0 million in 2023, then gained by 26.51% to -$17.6 million in 2024, then surged by 168.75% to $12.1 million in 2025, then grew by 12.02% to $13.6 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $13.6 million in Q1 2026, $12.1 million in Q4 2025, and $9.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.58 Mn |
| Dec 31, 2025 | 12.12 Mn |
| Sep 30, 2025 | 9.32 Mn |
| Jun 30, 2025 | 11.56 Mn |
| Mar 31, 2025 | 12.03 Mn |
| Dec 31, 2024 | -17.63 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Jun 30, 2024 | 25.31 Mn |
| Mar 31, 2024 | 27.99 Mn |
| Dec 31, 2023 | -23.99 Mn |
| Sep 30, 2023 | 10.72 Mn |
| Jun 30, 2023 | 12.15 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | -15.10 Mn |
| Sep 30, 2022 | 23.30 Mn |
| Jun 30, 2022 | 24.50 Mn |
| Mar 31, 2022 | 17.64 Mn |
| Dec 31, 2021 | -21.51 Mn |
| Sep 30, 2021 | -16.39 Mn |
| Jun 30, 2021 | 7.77 Mn |